- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07643207
Wearable Spine Assessment in Adults With and Without Low Back or Neck Pain (AxiSens-01)
Wearable Spine Assessment in Adults With and Without Low Back or Neck Pain: A Single-Site Observational Feasibility and Validity Study
This is a single-site, prospective, observational, single-visit feasibility and validity study. Adult participants with and without low back or neck pain will be screened, consented, and enrolled to undergo a structured wearable-sensor-based spine assessment in a single on-site visit.
Approximately 20 participants will be enrolled at a single site:
- Approximately 10 adults with self-reported chronic or subacute low back or neck pain (LBP/Neck Pain group)
- Approximately 10 adults without current back or neck pain (Control group)
The AxiSens battery includes the Fingertip-to-Floor (FTF) test for lumbar flexion, the Chin-to-Chest (CTC) test for cervical flexion, a seated Trunk Stability Test on an unstable surface, the Cervical Flexor Endurance Test, the five-times sit-to-stand F5xSTS) test, and a brief functional task module covering overhead and forward reach.
To support intra-rater repeatability characterization, the AxiSens wearable assessment is performed twice within the same visit by a single trained operator, with sensor doffing and re-donning between the two assessments. A short rest interval is provided between the two assessments.
Following the on-site assessment, participants complete a brief end-of-session usability and tolerability questionnaire and the Technology Acceptance Model (TAM) questionnaire.
Visão geral do estudo
Status
Condições
Descrição detalhada
Low back and neck pain are among the most common, costly, and disabling musculoskeletal conditions in the United States and worldwide. Low back pain is the leading cause of years lived with disability globally, and neck pain is consistently within the top ten. Both are leading drivers of healthcare expenditure, exceeding spending on diabetes, heart disease, and cancer in some recent analyses. Despite this magnitude, the clinical assessment of spine function remains heavily reliant on subjective self-report and clinician examination, with limited use of objective, quantitative, point-of-care measurement tools.
Wearable sensors, particularly inertial measurement units (IMUs), have matured into a credible technology base for objective musculoskeletal assessment. Multiple research groups have published validation studies establishing the accuracy of IMU-based segmental kinematics against optical motion capture, and feasibility studies demonstrating the utility of wearable kinematics in occupational and clinical settings. Most published wearable-spine assessment work to date has focused on lumbar kinematics in isolation, with cervical kinematic assessment less well-developed and integrated full-spine kinematic assessment relatively rare.
Recent peer-reviewed work demonstrated the feasibility of using wearable IMU technology to objectively assess cervical and upper-back posture in high-risk professional populations during prolonged work tasks. This work established that IMU-based monitoring of upper-body kinematics is feasible in real-world settings and that the methodology generates objective, reproducible data suitable for biofeedback and longitudinal monitoring. The current study extends this established methodology to a broader spine assessment configuration covering cervical, thoracic, lumbar, and pelvic segments, and integrated with validated patient-reported outcome instruments to enable a holistic biopsychosocial assessment of spine function.
The objective of this study is to evaluate the ability of a wearable, multi-modal spine assessment system - AxiSens - to discriminate between adults with low back or neck pain and healthy controls, and to characterize its intra-rater repeatability and workflow feasibility. There is no investigational therapeutic intervention. All participants undergo the same wearable-sensor-based spine assessment procedures in a single on-site visit. Approximately 20 participants will be enrolled, comprising approximately 10 participants in the LBP/Neck Pain group and approximately 10 participants in the Control group.
To support intra-rater repeatability characterization within this single-visit design, the AxiSens wearable assessment is performed twice within the visit by a single trained operator, with sensor doffing and re-donning between the two assessments and a short rest interval. The two within-visit assessments support estimation of the intra-rater repeatability of AxiSens-derived kinematic and composite outcomes.
Tipo de estudo
Inscrição (Estimado)
Contactos e Locais
Contato de estudo
- Nome: Ashkan Vaziri, PhD
- Número de telefone: 888-589-6213
- E-mail: ashkan.vaziri@biosensics.com
Locais de estudo
-
-
Massachusetts
-
Newton, Massachusetts, Estados Unidos, 02458
- Recrutamento
- BioSensics LLC
-
Contato:
- Ana Enriquez, BS
- Número de telefone: 888-589-6213
- E-mail: ana.enriquez@biosensics.com
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
- Male or female, aged 18-65 years
- Fluent in English (able to speak and read)
- Ambulatory without the need for a walking aid
- Able to independently perform all study activities safely, as determined by the investigator
- Willing and able to provide informed consent and comply with all study procedures
For LBP/Neck Pain participants:
- Self-reported low back or neck pain present for at least 4 weeks (subacute or chronic), with current Numeric Pain Rating Scale (NPRS) score of 3 or higher in the past 7 days
- No history of spine surgery within the past 12 months
For Control participants:
• No current low back or neck pain (NPRS < 2 in the past 30 days) and no history of clinically significant spine condition or spine surgery
Exclusion Criteria:
Participants meeting any of the following criteria will be excluded from the study:
- History of spine fracture, spinal deformity (e.g., scoliosis with Cobb angle > 25°), or spinal cord injury
- Active radicular signs requiring imaging or specialist referral, as determined by the investigator
- Neurological, vestibular, or musculoskeletal condition that would interfere with safe performance of the study tasks
- Pregnant individuals
- Skin condition or adhesive sensitivity precluding sensor application
- Body mass index (BMI) < 18 kg/m² or > 40 kg/m²
- Inability to provide informed consent or comply with study procedures
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
|---|
|
Control
Adults without low back or neck pain
|
|
Low back pain group
Adults with low back pain
|
|
Neck Pain
Adults with neck pain
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Group discrimination between control/low back pain/neck pain - Peak lumbar flexion range of motion
Prazo: Baseline Visit
|
AxiSens system shall discriminate between groups based on peak lumbar flexion range of motion and lumbopelvic coordination ration during the Fingertip to Floor test.
|
Baseline Visit
|
|
Group discrimination between control/low back pain/neck pain - Peak cervical flexion range of motion
Prazo: Baseline Visit
|
AxiSens system shall discriminate between groups based on peak cervical flexion range of motion and cervicothoracic coordination ration during the Chin to Chest test.
|
Baseline Visit
|
|
Group discrimination between control/low back pain/neck pain - Angular variability
Prazo: Baseline Visit
|
AxiSens system shall discriminate between groups based on angular variability of the sagittal and frontal planes during the Trunk Stability test in eyes open and eyes closed conditions.
|
Baseline Visit
|
|
Group discrimination between control/low back pain/neck pain - Cervical flexor endurance time
Prazo: Baseline Visit
|
AxiSens system shall discriminate between groups based on endurance time during the Cervical Flexor Endurance test.
|
Baseline Visit
|
|
Group discrimination between control/low back pain/neck pain - Five times sit-to-stand completion time
Prazo: Baseline Visit
|
AxiSens system shall discriminate between groups based on completion time during the five times sit-to-stand test.
|
Baseline Visit
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Numeric Pain Rating Scale
Prazo: Baseline Visit
|
The Numeric Pain Rating Scale (NPRS) is an 11-point, self-reported assessment tool where 0 means "no pain" and 10 represents the "worst pain imaginable."
It is scored simply by recording the whole number indicated by the patient, usually evaluated for current, average, or worst pain levels.
|
Baseline Visit
|
|
Neck Disability Index
Prazo: Baseline Visit
|
The Neck Disability Index (NDI) is a 10-question survey that measures how neck pain affects activities of daily life.
Each section is scored from 0 to 5, where 5 is a worst outcome.
The total is calculated as a percentage to determine the level of functional disability.
|
Baseline Visit
|
|
Oswestry Disability Index
Prazo: Baseline Visit
|
The Oswestry Disability Index (ODI) is the gold standard patient-reported questionnaire used to quantify functional disability in individuals with low back pain. It evaluates 10 everyday activities, such as personal care, lifting, walking, and sleeping. Each of the 10 sections is rated on a 6-point scale from 0 to 5, where 0 indicates no disability and 5 represents the most severe disability. |
Baseline Visit
|
|
Pain, Enjoyment, General Activity (PEG-3)
Prazo: Baseline Visit
|
The PEG-3 is used to assess chronic pain.
Patients rate their pain, enjoyment of life, and general activity on a scale of 0 to 10 based on the past week.
A higher score indicates a worst outcome.
|
Baseline Visit
|
Colaboradores e Investigadores
Patrocinador
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- AxiSens-01
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Dor lombar
-
Cancer Institute and Hospital, Chinese Academy...RecrutamentoHER2-Low Low irressectável/metastático câncer de mama complicado com crise visceralChina
-
National Taiwan University HospitalBuddhist Tzu Chi General Hospital; Taipei Medical University Hospital; E-DA Hospital e outros colaboradoresDesconhecidoColonoscopia | Limpeza do cólon | Dieta Low-ResideTaiwan
-
Université Victor Segalen Bordeaux 2Nanox International Laboratory (Belgique)ConcluídoEficácia e Tolerância do B-Back® na Síndrome de BurnoutFrança
-
Shanghai Henlius BiotechRecrutamentoHER2-Low Hormon Receptor positivo Câncer de mamaChina
-
Aminex Therapeutics, Inc.RecrutamentoMelanoma (câncer de pele) | HER2-Low Hormon Receptor positivo Câncer de mamaEstados Unidos
-
Yeon Hee ParkHelsinn Healthcare SAInscrevendo-se por convitePacientes com câncer de mama avançado positivo para HER2 tratado com T-DXD | Pacientes com câncer de mama Avançado com HER2-Low tratado com T-DXDCoréia do Sul
-
National Cancer Institute (NCI)RecrutamentoCâncer de Mama Anatômico Estágio III AJCC v8 | Câncer de Mama Anatômico Estágio IV AJCC v8 | Neoplasia sólida maligna irressecável | Neoplasia Sólida Maligna Metastática | Carcinoma de Mama Invasivo | Carcinoma de mama irressecável | Carcinoma de Mama Triplo Negativo Metastático | Carcinoma de Mama... e outras condiçõesEstados Unidos
-
BicycleTx LimitedAtivo, não recrutandoNeoplasias da Mama | Neoplasias da Mama Triplo Negativas | Tumor Sólido Avançado | Neoplasia ovariana | Neoplasia da Bexiga Urinária | Neoplasias positivas para receptor hormonal e negativas para HER2 | Receptor hormonal positivo, neoplasias HER2-low | Neoplasias pulmonares de células não pequenasFrança, Estados Unidos, Espanha, Reino Unido, Itália, Canadá
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Fondazione Policlinico Universitario Agostino Gemelli IRCCS; Fondazione IRCCS... e outros colaboradoresRecrutamentoCâncer de mama | Neoplasias da Mama | Doenças da mama | Neoplasia de Mama | Tumores de mama | Carcinoma de mama | Neoplasias da Mama, Masculino | Câncer de Mama Estágio IV | Neoplasia Maligna da Mama Receptor Hormonal Positivo | Câncer de Mama RH positivo | Carcinoma de Mama Receptor Hormonal Positivo | Câncer... e outras condiçõesItália